 |
The Journal of Neuroscience, April 21, 2004, 24(16):4052-4060; doi:10.1523/JNEUROSCI.5449-03.2004
Previous Article | Next Article 
Neurobiology of Disease
Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN
Ke Ning,1,2,3
Lin Pei,4,5
Mingxia Liao,1,2,3
Baosong Liu,1,2,3
Yunzhou Zhang,6
Wen Jiang,6
John G. Mielke,1
Lei Li,1,2,3
Yonghong Chen,1,2,3
Youssef H. El-Hayek,1,2,3
Michael G. Fehlings,1,3
Xia Zhang,6
Fang Liu,4,5
James Eubanks,1,3 and
Qi Wan1,2,3
1Division of Cellular and Molecular Biology, Toronto Western Research Institute, University Health Network, Toronto, Canada M5T 2S8, Departments of 2Physiology, 3Surgery, and 4Psychiatry, University of Toronto, Toronto, Canada M5S 1A8, 5Centre for Addiction and Mental Health, Clarke Division, Toronto, Canada M5T 1R8, and 6Neuropsychiatry Research Unit, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E4
The tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a lipid and protein phosphatase. We report here that PTEN physically associates with the NR1 and NR2B subunits of NMDA receptors (NMDARs) in rat hippocampus. Downregulating the protein expression of PTEN inhibits the function of extrasynaptic NMDARs and decreases NMDAR surface expression, suggesting a crucial role for endogenous PTEN in the modulation of NMDAR-mediated neuronal function. Reducing PTEN expression also enhances Akt/Bad phosphorylation in hippocampal neurons. Importantly, suppressing lipid and protein phosphatase activity of PTEN, respectively, activates Akt and inhibits extrasynaptic NMDAR activity and thereby protects against ischemic neuronal death in vitro and in vivo. Thus, our study reveals a dual neuroprotective mechanism by which Akt/Bad and extrasynaptic NMDARs are regulated via downregulation of two distinct PTEN phosphatase activities and present the possibility of PTEN as a potential therapeutic target for stroke treatment.
Key words: phosphatase; NMDA receptor; cerebral ischemia; neuroprotection; stroke; synapse
Received Dec 10, 2003;
revised March 8, 2004;
accepted March 8, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
G. Li, L. Han, T.-C. Chou, Y. Fujita, L. Arunachalam, A. Xu, A. Wong, S.-K. Chiew, Q. Wan, L. Wang, et al.
RalA and RalB Function as the Critical GTP Sensors for GTP-Dependent Exocytosis
J. Neurosci.,
January 3, 2007;
27(1):
190 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Kim, K. Yamashita, J. H. Baek, H. L. Park, A. L. Carvalho, M. Osada, M. O. Hoque, S. Upadhyay, M. Mori, C. Moon, et al.
N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.
Cancer Res.,
April 1, 2006;
66(7):
3409 - 3418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, T. Shimohata, J. Q. Wang, G. Sun, D. W. Schaal, R. M. Sapolsky, and G. K. Steinberg
Akt Contributes to Neuroprotection by Hypothermia against Cerebral Ischemia in Rats
J. Neurosci.,
October 19, 2005;
25(42):
9794 - 9806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhou, Q. Liu, and R. L. Davis
Complex Regulation of Spiral Ganglion Neuron Firing Patterns by Neurotrophin-3
J. Neurosci.,
August 17, 2005;
25(33):
7558 - 7566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, W. Ouyang, J. Li, L. Wei, Q. Ma, Z. Zhang, Q. Tong, J. He, and C. Huang
Loss of Tumor Suppressor p53 Decreases PTEN Expression and Enhances Signaling Pathways Leading to Activation of Activator Protein 1 and Nuclear Factor {kappa}B Induced by UV Radiation
Cancer Res.,
August 1, 2005;
65(15):
6601 - 6611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zou, L. Li, L. Pei, B. Vukusic, H. H. M. Van Tol, F. J. S. Lee, Q. Wan, and F. Liu
Protein-Protein Coupling/Uncoupling Enables Dopamine D2 Receptor Regulation of AMPA Receptor-Mediated Excitotoxicity
J. Neurosci.,
April 27, 2005;
25(17):
4385 - 4395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Waxman and D. R. Lynch
N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease
Neuroscientist,
February 1, 2005;
11(1):
37 - 49.
[Abstract]
[PDF]
|
 |
|
|

|